Allocetra injection for jaw joint arthritis
Part of Bones, joints & muscles clinical trials.
This study tests a new injection called Allocetra directly into the jaw joint to treat pain and inflammation in temporomandibular joint osteoarthritis. Eligible participants must have MRI-confirmed inflammation and meet basic health requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with osteoarthritis in your jaw joint (TMJ).
- An MRI of your jaw joint shows signs of inflammation.
- Your blood tests (complete blood count, electrolytes, kidney and liver function) are within normal limits.
- You have not had an injection in the jaw joint within the past 3 months.
- You have not had surgery or a significant injury to the jaw joint.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether injecting iPRF (a therapy made from your blood growth factors) into the jaw joint can reduce symptoms from mild to moderate jaw joint degeneration. It’s being compared against standard care for people who currently are not on other jaw-joint treatments.
This study tests a new cell-based injection (Allocetra) directly into the knee joint for people with moderate osteoarthritis who haven't benefited from other treatments. The goal is to reduce pain and improve knee function.
This trial compares two ways of giving a treatment injection into the jaw joint for people with painful jaw joint problems. One method uses a small camera during a procedure called arthroscopy, and the other uses an ultrasound to guide the needle.
This study tests whether a combination of two medicines (triamcinolone and lidocaine) injected into the jaw muscle (masseter) helps reduce jaw pain better than a placebo. It's a randomized trial, meaning participants are assigned by chance to get the active injection or a dummy injection.
This trial tests a calcium gluconate injection into the jaw joint for people with painful jaw joint disc displacement that hasn't improved with other treatments. The injection may help reduce pain and improve jaw function.
This trial tests two types of hyaluronic acid (high vs low molecular weight) given during a jaw joint procedure (arthrocentesis) to see which better relieves pain and improves jaw function in people with TMJ disorders.
Hear when a new Temporomandibular Joint Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.